Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5600
0.00 (0.00%)
At close: May 21, 2026
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 29.03 million as of May 21, 2026. Its market cap has increased by 14.69% in one year.
Market Cap
29.03M
Enterprise Value
27.41M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.56
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 29.03M, an increase of 108.01%. That is a compound annual growth rate of 19.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 29.03M | -13.85% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 58.44M |
| Quantum BioPharma | 54.10M |
| Medicenna Therapeutics | 45.05M |
| MedMira | 42.10M |
| Lobe Sciences | 38.35M |
| Defence Therapeutics | 37.89M |
| Devonian Health Group | 31.01M |
| Microbix Biosystems | 31.00M |